BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

1116 related articles for article (PubMed ID: 18196534)

  • 21. JNK/c-Jun signaling mediates an anti-apoptotic effect of RANKL in osteoclasts.
    Ikeda F; Matsubara T; Tsurukai T; Hata K; Nishimura R; Yoneda T
    J Bone Miner Res; 2008 Jun; 23(6):907-14. PubMed ID: 18251700
    [TBL] [Abstract][Full Text] [Related]  

  • 22. ROS-mediated p38alpha MAPK activation and ERK inactivation responsible for upregulation of Fas and FasL and autocrine Fas-mediated cell death in Taiwan cobra phospholipase A(2)-treated U937 cells.
    Liu WH; Cheng YC; Chang LS
    J Cell Physiol; 2009 Jun; 219(3):642-51. PubMed ID: 19180563
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Mitomycin-C induces the apoptosis of human Tenon's capsule fibroblast by activation of c-Jun N-terminal kinase 1 and caspase-3 protease.
    Seong GJ; Park C; Kim CY; Hong YJ; So HS; Kim SD; Park R
    Invest Ophthalmol Vis Sci; 2005 Oct; 46(10):3545-52. PubMed ID: 16186332
    [TBL] [Abstract][Full Text] [Related]  

  • 24. C-Jun N-terminal kinase is required for phorbol ester- and thapsigargin-induced apoptosis in the androgen responsive prostate cancer cell line LNCaP.
    Engedal N; Korkmaz CG; Saatcioglu F
    Oncogene; 2002 Feb; 21(7):1017-27. PubMed ID: 11850819
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Non-apoptotic Fas signaling regulates invasiveness of glioma cells and modulates MMP-2 activity via NFkappaB-TIMP-2 pathway.
    Wisniewski P; Ellert-Miklaszewska A; Kwiatkowska A; Kaminska B
    Cell Signal; 2010 Feb; 22(2):212-20. PubMed ID: 19788921
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Doxorubicin and selenium cooperatively induce fas signaling in the absence of Fas/Fas ligand interaction.
    Li S; Zhou Y; Dong Y; Ip C
    Anticancer Res; 2007; 27(5A):3075-82. PubMed ID: 17970047
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Requirement for Daxx in mature T-cell proliferation and activation.
    Leal-Sanchez J; Couzinet A; Rossin A; Abdel-Sater F; Chakrabandhu K; Luci C; Anjuere F; Stebe E; Hancock D; Hueber AO
    Cell Death Differ; 2007 Apr; 14(4):795-806. PubMed ID: 17082815
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Deregulated c-Myc prematurely recruits both Type I and II CD95/Fas apoptotic pathways associated with terminal myeloid differentiation.
    Amanullah A; Liebermann DA; Hoffman B
    Oncogene; 2002 Feb; 21(10):1600-10. PubMed ID: 11896589
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Arachidonic acid induces Fas and FasL upregulation in human leukemia U937 cells via Ca2+/ROS-mediated suppression of ERK/c-Fos pathway and activation of p38 MAPK/ATF-2 pathway.
    Liu WH; Chang LS
    Toxicol Lett; 2009 Dec; 191(2-3):140-8. PubMed ID: 19720122
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Ursolic acid induces PC-3 cell apoptosis via activation of JNK and inhibition of Akt pathways in vitro.
    Zhang Y; Kong C; Zeng Y; Wang L; Li Z; Wang H; Xu C; Sun Y
    Mol Carcinog; 2010 Apr; 49(4):374-85. PubMed ID: 20146252
    [TBL] [Abstract][Full Text] [Related]  

  • 31. FADD is required for multiple signaling events downstream of the receptor Fas.
    Juo P; Woo MS; Kuo CJ; Signorelli P; Biemann HP; Hannun YA; Blenis J
    Cell Growth Differ; 1999 Dec; 10(12):797-804. PubMed ID: 10616904
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Activation of the Fas-FasL signaling pathway by MDA-7/IL-24 kills human ovarian cancer cells.
    Gopalan B; Litvak A; Sharma S; Mhashilkar AM; Chada S; Ramesh R
    Cancer Res; 2005 Apr; 65(8):3017-24. PubMed ID: 15833826
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Guggulsterone-induced apoptosis in human prostate cancer cells is caused by reactive oxygen intermediate dependent activation of c-Jun NH2-terminal kinase.
    Singh SV; Choi S; Zeng Y; Hahm ER; Xiao D
    Cancer Res; 2007 Aug; 67(15):7439-49. PubMed ID: 17671214
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Resveratrol induces FasL-related apoptosis through Cdc42 activation of ASK1/JNK-dependent signaling pathway in human leukemia HL-60 cells.
    Su JL; Lin MT; Hong CC; Chang CC; Shiah SG; Wu CW; Chen ST; Chau YP; Kuo ML
    Carcinogenesis; 2005 Jan; 26(1):1-10. PubMed ID: 15217905
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Interruption of nuclear factor kappaB signaling by the androgen receptor facilitates 12-O-tetradecanoylphorbolacetate-induced apoptosis in androgen-sensitive prostate cancer LNCaP cells.
    Altuwaijri S; Lin HK; Chuang KH; Lin WJ; Yeh S; Hanchett LA; Rahman MM; Kang HY; Tsai MY; Zhang Y; Yang L; Chang C
    Cancer Res; 2003 Nov; 63(21):7106-12. PubMed ID: 14612503
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Vitamin E succinate (VES) induces Fas sensitivity in human breast cancer cells: role for Mr 43,000 Fas in VES-triggered apoptosis.
    Yu W; Israel K; Liao QY; Aldaz CM; Sanders BG; Kline K
    Cancer Res; 1999 Feb; 59(4):953-61. PubMed ID: 10029090
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The ribonucleotide reductase R1 subunits of herpes simplex virus types 1 and 2 protect cells against TNFα- and FasL-induced apoptosis by interacting with caspase-8.
    Dufour F; Sasseville AM; Chabaud S; Massie B; Siegel RM; Langelier Y
    Apoptosis; 2011 Mar; 16(3):256-71. PubMed ID: 21107701
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Expression of a dominant negative form of Daxx in vivo rescues motoneurons from Fas (CD95)-induced cell death.
    Raoul C; Barthelemy C; Couzinet A; Hancock D; Pettmann B; Hueber AO
    J Neurobiol; 2005 Feb; 62(2):178-88. PubMed ID: 15459896
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Involvement of the TNF-alpha autocrine-paracrine loop, via NF-kappaB and YY1, in the regulation of tumor cell resistance to Fas-induced apoptosis.
    Huerta-Yepez S; Vega M; Garban H; Bonavida B
    Clin Immunol; 2006 Sep; 120(3):297-309. PubMed ID: 16784892
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Involvement of activator protein-1 (AP-1) in induction of apoptosis by vitamin E succinate in human breast cancer cells.
    Zhao B; Yu W; Qian M; Simmons-Menchaca M; Brown P; Birrer MJ; Sanders BG; Kline K
    Mol Carcinog; 1997 Jul; 19(3):180-90. PubMed ID: 9254885
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 56.